Segment Information
Revenue
(Thousand yen)
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
|
---|---|---|---|---|---|
Information Infrastructure Business | 16,957,584 | 19,006,737 | 20,943,188 | 24,711,247 | 29,305,598 |
Application Services Business | 8,460,865 | 9,546,507 | 9,985,317 | 7,242,041 | 7,300,580 |
Medical System Business | - | - | - | 4,560,330 | 9,344,434 |
*The Company voluntarily adopted the International Financial Reporting Standards (IFRS) for its securities report for the fiscal year ended March 31, 2021.
*Financial results on this page before 2020 are based on Japanese GAAP, and after the fiscal year ending March 2021 are based on IFRS.
*FY2021 figures for the Application Services business do not include figures for the medical field.
*Medical System Business Unit was spun off from the Application Services Business Unit in FY2022.
*FY2021 results for medical systems business are the sum of former NOBORI, ICHIGO, and A-Line, plus the results of former PSP.FY2022 results are the sum of new PSP, ICHIGO, and A-Line.
*Financial results on this page before 2020 are based on Japanese GAAP, and after the fiscal year ending March 2021 are based on IFRS.
*FY2021 figures for the Application Services business do not include figures for the medical field.
*Medical System Business Unit was spun off from the Application Services Business Unit in FY2022.
*FY2021 results for medical systems business are the sum of former NOBORI, ICHIGO, and A-Line, plus the results of former PSP.FY2022 results are the sum of new PSP, ICHIGO, and A-Line.
■ Information Infrastructure Business | 29,305,598 | |
■ Application Services Business | 7,300,580 | |
■ Medical System Business | 9,344,434 |
Operating profit
(Thousand yen)
2019/3 |
2020/3 |
2021/3 |
2022/3 |
2023/3 |
|
---|---|---|---|---|---|
Information Infrastructure Business | 1,777,893 | 2,280,735 | 2,741,740 | 3,054,819 | 3,125,487 |
Application Services Business | 640,970 | 747,568 | 841,777 | -48,559 | -20,955 |
Medical System Business | - | - | - | 728,248 | 1,993,907 |
*The Company voluntarily adopted the International Financial Reporting Standards (IFRS) for its securities report for the fiscal year ended March 31, 2021.
*Financial results on this page before 2020 are based on Japanese GAAP, and after the fiscal year ending March 2021 are based on IFRS.
*FY2021 figures for the Application Services business do not include figures for the medical field.
*Medical System Business Unit was spun off from the Application Services Business Unit in FY2022.
*FY2021 results for medical systems business are the sum of former NOBORI, ICHIGO, and A-Line, plus the results of former PSP.FY2022 results are the sum of new PSP, ICHIGO, and A-Line.
*Financial results on this page before 2020 are based on Japanese GAAP, and after the fiscal year ending March 2021 are based on IFRS.
*FY2021 figures for the Application Services business do not include figures for the medical field.
*Medical System Business Unit was spun off from the Application Services Business Unit in FY2022.
*FY2021 results for medical systems business are the sum of former NOBORI, ICHIGO, and A-Line, plus the results of former PSP.FY2022 results are the sum of new PSP, ICHIGO, and A-Line.
■ Information Infrastructure Business | 3,125,487 | |
■ Application Services Business | -20,955 | |
■ Medical System Business | 1,993,907 |